Open Nav

Flaskworks LLC

  • Jennifer Rossi, Flaskworks

Attract and meet investors for the A Round

  • Date:Wednesday, October 17
  • Time:3:15 PM - 3:30 PM
  • Room:Elizabethan A
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Flaskworks aims to transform the manufacture of dendritic cells for the rapidly growing immuno-oncology and dendritic-cell based vaccine markets. These promising therapies utilize cells which are currently developed using costly, error-prone and time-consuming manual techniques. Flaskworks is developing modular, closed and disposable systems able to address the bottlenecks in the manufacture of these promising therapies. Our pipeline of instrumentation and associated consumables for both the manufacture of dendritic cells and the stimulation and expansion of T cells have been developed in a laboratory at Northeastern University and exclusively licensed to Flaskworks. The team has considerable experience developing and commercializing instrumentation for life science and pharma. Significant grant funding and testing at academic medical centers, biotechs and pharma companies has enabled a market ready product to date.
  • Company
  • Company HQ City:Boston
  • Company HQ Country:United States
  • Company HQ State:Massachusetts       
  • CEO/Top Company Official:Jennifer Rossi
  • Year Founded:2016
  • Main Therapeutic Focus:Platform for Therapeutics
  • Lead Product in Development :MicroDEN system for dendritic cell generation
  • Development Phase of Primary Product:Other/Not Applicable
  • Additional Information/Comments:By the time of this forum we will be able to announce commercial partners for our products as well as the launch of our first instrument and associated consumables. We have just received two government SBIR grants based to perform additional work on this technology.
  • Previous and Current Investors:not yet disclosed
  • Size of Last Investment Round:closing soon
  • Total Amount Raised to Date, In All Rounds:Seed round in process. ~$1.2M in grant funding
Jennifer Rossi